Teladoc Health, Inc. (NYSE:TDOC) 42nd Annual JPMorgan Healthcare Conference January 9, 2024 4:30 PM ET Company Participants Jason Gorevic - CEO Conference Call Participants Lisa Gill - JPMorgan Lisa Gill Good afternoon. My name is Lisa Gill, and I am the Head of Healthcare Services at JPMorgan. With me this afternoon, I have Teladoc Health. Presenting for Teladoc is CEO, Jason Gorevic. When Jason has done with his presentation, he'll join me over here, and we'll have a little fireside chat. So with that, ...

In the latest market close, Teladoc (TDOC) reached $21.36, with a +0.56% movement compared to the previous day. This move outpaced the S&P 500's daily loss of 0.34%. Meanwhile, the Dow gained 0.03%, and the Nasdaq, a tech-heavy index, lost 0.56%.The telehealth services provider's stock has climbed by 12.02% in the past month, exceeding the Medical sector's gain of 5.72% and the S&P 500's gain of 2.56%.Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. The ...

Telehealth leader Teladoc Health (TDOC -2.49%) is suffering the same fate as many other so-called "pandemic stocks." Since the health crisis is largely in the rear-view mirror (even if COVID itself is not), the traction that the company gained from it has faded -- and then some. Teladoc shares are down by 89% in the past three years, and are trading well below where they were before the pandemic began.Still, there remain excellent reasons to invest in Teladoc, particularly for investors willing to hold its ...

PURCHASE, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that Jason Gorevic, chief executive officer, and Mala Murthy, chief financial officer, will participate in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 9th, 2024. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/. About Teladoc HealthTel ...

Teladoc Health, Inc. (NYSE:TDOC) 35th Annual Piper Sandler Healthcare Conference November 28, 2023 12:00 PM ET Company Participants Jason Gorevic - Chief Executive Officer Conference Call Participants Jessica Tassan - Piper Sandler Jessica Tassan All right. So, good afternoon everyone, my name is Jessica Tassan. I'm the healthcare services analyst at Piper. And I'm thrilled to be here with Jason Gorevic, CEO of Teladoc, the country's largest and most diversified digital healthcare platform, and serving over ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________ Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-37477 _______ ...

Company Participants Conference Call Participants Teladoc Health, Inc. (NYSE:TDOC) Q3 2023 Earnings Conference Call October 24, 2023 4:30 PM ET Jason Gorevic - Chief Executive Officer Lisa Gill - JPMorgan Jailendra Singh - Truist Lucas Romanski - TD Cowen Jessica Tassan - Piper Sandler Elizabeth Anderson - Evercore ISI Operator I'd now like to pass the conference over to our host, Patrick Feeley, Head of Investor Relations. Patrick, please go ahead. Thank you and good afternoon. Today, after the market clos ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________ Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 ___________________________ ...

Fair enough. That's helpful. Thank you. David Larsen Okay. Thank you. Operator Thank you. Our next question comes from Elizabeth Anderson of Evercore. Elizabeth, your line is now open. Please go ahead. Elizabeth Anderson Hi, guys. Thanks so much for the question and congrats on a nice quarter. I was wondering if you could talk a little bit about some of the productivity improvement, I think, Mala, that you mentioned. Is that sort of a result of like new initiatives that you're doing? I assume it's sort of t ...

(in 000s) Reconciliation of GAAP Gross Profit to Adj. Gross Profit & Adj. Gross Margin | --- | --- | --- | --- | --- | --- | |------------------------------------------------------------------------------------------------|-----------|-----------------------------------------------|-----------|-----------|-----------| | | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | | Revenue | | $592,379 $611,402 $637,709 $629,244 $ 652,406 | | | | | Cost of revenue (exclusive of depreciation and amortization, which i ...